Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Net Margin (2016 - 2025)

Historic Net Margin for Traws Pharma (TRAW) over the last 14 years, with Q2 2025 value amounting to 22.87%.

  • Traws Pharma's Net Margin rose 364227500.0% to 22.87% in Q2 2025 from the same period last year, while for Sep 2025 it was 351.23%, marking a year-over-year increase of 136540800.0%. This contributed to the annual value of 24192.04% for FY2024, which is 158079600.0% down from last year.
  • Traws Pharma's Net Margin amounted to 22.87% in Q2 2025, which was up 364227500.0% from 26461.4% recorded in Q1 2025.
  • Traws Pharma's 5-year Net Margin high stood at 26461.4% for Q1 2025, and its period low was 38248.21% during Q4 2024.
  • In the last 5 years, Traws Pharma's Net Margin had a median value of 8027.79% in 2023 and averaged 8863.29%.
  • As far as peak fluctuations go, Traws Pharma's Net Margin crashed by -302803600bps in 2024, and later surged by 364227500bps in 2025.
  • Traws Pharma's Net Margin (Quarter) stood at 6719.64% in 2021, then plummeted by -52bps to 10239.29% in 2022, then rose by 22bps to 7967.86% in 2023, then plummeted by -380bps to 38248.21% in 2024, then soared by 100bps to 22.87% in 2025.
  • Its Net Margin stands at 22.87% for Q2 2025, versus 26461.4% for Q1 2025 and 38248.21% for Q4 2024.